These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34610482)

  • 1. Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder.
    Guerdjikova AI; Romo-Nava F; Blom TJ; Mori N; McElroy SL
    Contemp Clin Trials; 2021 Nov; 110():106587. PubMed ID: 34610482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
    Dalai SS; Adler S; Najarian T; Safer DL
    Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial.
    McElroy SL; Hudson JI; Grilo CM; Guerdjikova AI; Deng L; Koblan KS; Goldman R; Navia B; Hopkins S; Loebel A
    J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.
    McElroy SL; Guerdjikova A; Kotwal R; Welge JA; Nelson EB; Lake KA; Keck PE; Hudson JI
    J Clin Psychiatry; 2007 Mar; 68(3):390-8. PubMed ID: 17388708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.
    McElroy SL; Hudson JI; Gasior M; Herman BK; Radewonuk J; Wilfley D; Busner J
    Int J Eat Disord; 2017 Aug; 50(8):884-892. PubMed ID: 28481434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety, and tolerability of nivasorexant in adults with binge-eating disorder: A randomized, Phase II proof of concept trial.
    McElroy SL; Coloma PM; Berger B; Guerdjikova AI; Joyce JM; Liebowitz MR; Pain S; Rabasa C
    Int J Eat Disord; 2023 Nov; 56(11):2120-2130. PubMed ID: 37584285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
    Schweitzer PK; Rosenberg R; Zammit GK; Gotfried M; Chen D; Carter LP; Wang H; Lu Y; Black J; Malhotra A; Strohl KP;
    Am J Respir Crit Care Med; 2019 Jun; 199(11):1421-1431. PubMed ID: 30521757
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
    McElroy SL; Hudson JI; Mitchell JE; Wilfley D; Ferreira-Cornwell MC; Gao J; Wang J; Whitaker T; Jonas J; Gasior M
    JAMA Psychiatry; 2015 Mar; 72(3):235-46. PubMed ID: 25587645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
    Safer DL; Adler S; Dalai SS; Bentley JP; Toyama H; Pajarito S; Najarian T
    Int J Eat Disord; 2020 Feb; 53(2):266-277. PubMed ID: 31721257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder.
    Yee K; Serrano D; Kando J; McElroy SL
    Qual Life Res; 2019 Dec; 28(12):3385-3394. PubMed ID: 31473907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
    Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
    JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial.
    Guerdjikova AI; Mori N; Blom TJ; Keck PE; Williams SL; Welge JA; McElroy SL
    Hum Psychopharmacol; 2016 Sep; 31(5):382-91. PubMed ID: 27650406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies.
    Citrome L; Kando JC; Bliss C
    Neuropsychiatr Dis Treat; 2018; 14():537-546. PubMed ID: 29497297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
    Dauvilliers Y; Shapiro C; Mayer G; Lammers GJ; Emsellem H; Plazzi G; Chen D; Carter LP; Lee L; Black J; Thorpy MJ
    CNS Drugs; 2020 Jul; 34(7):773-784. PubMed ID: 32588401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
    Grilo CM; Lydecker JA; Morgan PT; Gueorguieva R
    Clin Ther; 2021 Jan; 43(1):112-122.e1. PubMed ID: 33218742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI
    J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as.
    Grilo CM; White MA
    Behav Res Ther; 2013 Mar; 51(3):167-75. PubMed ID: 23376451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.
    Brownley KA; Von Holle A; Hamer RM; La Via M; Bulik CM
    J Psychosom Res; 2013 Jul; 75(1):36-42. PubMed ID: 23751236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.
    Carter LP; Henningfield JE; Wang YG; Lu Y; Kelsh D; Vince B; Sellers E
    J Psychopharmacol; 2018 Dec; 32(12):1351-1361. PubMed ID: 30269642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binge-eating disorder treatment goes online - feasibility, usability, and treatment outcome of an Internet-based treatment for binge-eating disorder: study protocol for a three-arm randomized controlled trial including an immediate treatment, a waitlist, and a placebo control group.
    Munsch S; Wyssen A; Vanhulst P; Lalanne D; Steinemann ST; Tuch A
    Trials; 2019 Feb; 20(1):128. PubMed ID: 30760299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.